MGC Pharmaceuticals Ltd - MGC Pharmaceuticals gears up to pursue global growth strategy in 2021 MGC Pharmaceuticals gears up to pursue global growth strategy in 2021

The company is focused on its core business of executing its growth strategy and become a...

1 day, 9 hours ago
Deep dive

Paradigm Biopharmaceuticals lays out roadmap for the future at JP Morgan...

Paradigm will be focused on Phase 3 trials of its drug Zilosul® during 2021, COO Jeannie Joughin...

2 days, 8 hours ago
Deep dive

eSense-Lab continues development momentum into 2021

The company has created virtual cannabis, with all the characteristics of the real plant,...

4 days, 13 hours ago
Deep dive

Zoetic International makes rapid progress with CBD business

Zoetic grows its own hemp and sells CBD products in the US, UK and Europe

1 week, 1 day ago
Deep dive

CardieX on track to launch new products and digital solutions in 2021

The company is well funded and has a strong sales pipeline to launch new devices in home vital...

1 week, 2 days ago

Orthocell's Paul Anderson hails FDA approval for dental bone and tissue...

Orthocell Ltd's (ASX:OCC) Paul Anderson caught up with Proactive's Andrew Scott soon after announcing they've received Food and Drug Administration’s (FDA) 510(k) clearance to market and supply its CelGro collagen medical device for dental bone and tissue regeneration procedures in the US....

1 day, 16 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.